InVivo Therapeutics 2010 News

Boston Bruins Foundation and InVivo Therapeutics Corporation Honor Thomas E. Smith, Check Presentation to Take Place Monday December 20, 2010
December 17, 2010
On Monday, December 20 the Boston Bruins Foundation and InVivo Therapeutics (OTCBB: NVIV) will present a check for $15,000 dollars to Thomas E. Smith, founder of the Thomas E. Smith Fight to Cure Paralysis Foundation. The presentation will take place on-ice during the second intermission of the Bruins/Ducks game at the TD Garden (100 Legends Way, Boston, MA 02114).
Read More

InVivo Therapeutics Holdings Corporation Names George Nolen Former CEO of Siemens as Lead Director
December 13, 2010
InVivo Therapeutics today announced that the companys Board of Directors has appointed George Nolen, former President and CEO of Siemens Corporation and a Director of InVivo, to the position of Lead Director, effective December 10, 2010.
Read More

InVivo Therapeutics Closes Oversubscribed Private Placement, Raising $13 Million
December 6, 2010
InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it has successfully closed a private placement offering of 13 million units of its securities for total gross proceeds of $13 million.
Read More

InVivo Therapeutics to Present at Lazard Capital Markets Annual Healthcare Conference
November 10, 2010
InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, CEO of InVivo, will be presenting at the Lazard Capital Markets Annual Healthcare Conference on Tuesday, November 16, 2010 at 3:40 P.M. Eastern Time at the St. Regis Hotel in New York City.
Read More

InVivo Therapeutics CEO to Address 5th Annual Working 2 Walk Science & Advocacy Symposium
November 9, 2010
InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, CEO of InVivo, will address the 5th Annual Working 2 Walk Science & Advocacy Symposium taking place November 11 through 13, 2010 in Phoenix, Arizona. Mr. Reynolds remarks, titled Changing the Face of Neuroscience: Are Stem Cells Really Required to Heal a Spinal Cord Injury? will be given at 9:10am ET on Friday, November 12.
Read More

InVivo Therapeutics Opens New Manufacturing and Development Facility in Medford, Massachusetts to Support First Human Clinical Trial
November 1, 2010
InVivo Therapeutics Corporation, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it has signed a lease to open its first manufacturing and development facility in Medford, Massachusetts. The company expects to use this new facility to scale up the manufacturing process for its lead product candidate, a novel biocompatible polymer scaffolding device used to treat acute open-wound SCI.
Read More

InVivo Therapeutics Announces Reverse Merger and $10.5 Million Private Offering
Octoberr 27, 2010
InVivo Therapeutics Corporation, a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced the successful completion of a reverse merger with InVivo Therapeutics Holdings Corp. InVivo, now headquartered in Cambridge, Massachusetts, will continue the business of InVivo Therapeutics as a wholly-owned subsidiary under the leadership of InVivo Therapeutics current management team, headed by Chief Executive Officer, Frank Reynolds. In completing the Merger, InVivo issued approximately 31.6 million shares of its common stock to the holders of InVivo Therapeutics common stock. The merged company will be quoted on the OTC markets under the symbol “NVIV” beginning Thursday, October 28, 2010..
Read More

InVivo Therapeutics is Second Company to Repay Accelerator Loan from Massachusetts Life Sciences Center
Octoberr 27, 2010
Massachusetts Life Sciences Center President & CEO Susan WindhamBannister and InVivo Therapeutics today announced the Cambridgebased company’s repayment of the Center’s Accelerator Program loan.
Read More

InVivo Therapeutics names Christopher Pritchard Chief Science Officer
September 13, 2010
InVivo Therapeutics Corporation announced today that Christopher Pritchard will assume the role of Chief Science Officer, effective immediately. Dr. Pritchard has served several important research and development roles since he began his work with InVivo co-founder Frank Reynolds in 2007. His most recent position at InVivo was Director of Research & Development.
Read More

InVivo Therapeutics CEO to Present at TEDx Boston
June 30, 2010
Watch at YouTube
InVivo Therapeutics CEO Frank Reynolds has been invited to speak at the 2010 TEDxBoston conference, where x=independently organized TED event, which is designed to leverage ideas to help create a better world. The conference will be held at the World Trade Center Boston on July 29th, 2010. Presenters include innovators, leaders, educators and scientists who have a passion for their fields, and vary from executives of top global companies to creators of groundbreaking media.
Read More

InVivo Therapeutics CEO Frank Reynolds Honored Alongside Nobel Laureate Dr. James Watson
May 25, 2010
InVivo Therapeutics CEO Frank Reynolds was honored last Thursday alongside Nobel Laureate Dr. James Watson in a ceremony recognizing a select group of Irish Americans noted for their work and achievements in the life sciences industry.
Read More

InVivo Therapeutics Corporation Scientists Filmed for National Geographic Channel Documentary
May 18, 2010
National Geographic camera crews paid a visit to InVivo Therapeutics Corporation last Thursday, May 13, 2010 to capture footage of InVivo scientists as part of the development of a new documentary on tissue engineering. The piece, called The Replaceable You, will be aired on the National Geographic Channel later this year.

Read More

President of Ireland, Mary McAleese, to Honor Frank Reynolds, InVivo Therapeutics CEO, as one of ‘Irish Life Science 50’
April 23, 2010
InVivo Therapeutics Corporation CEO Frank Reynolds will be honored by the Irish Voice and Irish America Magazine, in collaboration with the Irish Government, as one of the ‘Irish Life Science 50.’The award is the first honor to be given to influential Irish Americans for their work in the field of life sciences and is aimed to recognize “diverse accomplishments and advancements in the industry,” according the Irish Voice.
Read More

InVivo Therapeutics CEO Meets with Massachusetts Governor Deval Patrick to Discuss Health Care Reform
March 31, 2010
InVivo Therapeutics CEO Frank Reynolds met with Massachusetts Governor Deval Patrick at the Massachusetts State House today in an advisory capacity regarding the national health care reform and its effect on the medical device sector in Massachusetts. Reynolds, along with the leaders of several other companies in the medical device industry such as Boston Scientific and Zoll, engaged in an open discussion with Governor Patrick and shared their opinions on the impact of the health care reform on the industry.
Read More

InVivo Therapeutics Corporation Featured in March Issue of Inc. Magazine and Publishes 50th Research Article in the Journal of Neuroscience Methods
March 3, 2010
In the same week, InVivo Therapeutics Corporation has been recognized for both its business and scientific achievements.
Read @ Inc.com Read More

Members of Russian Parliament Revisit InVivo Therapeutics Corporation
February 10, 2010
Several delegates from the Russian Parliament visited InVivo Therapeutics Corporation last month on Monday January 25, 2010. Among the representatives from the Russian government were Igor Shuvalov, First Deputy Primate Minister of the Russian Federation, Sergey Sobyanin, Deputy Prime Minister and Chief of the Government Staff, Arkady Dvorkovich, Aide to the President of the Russian Federation, and Elvire Nabiullina, Minister of Economic Development and Trade. The visitors had the chance to speak to InVivo Therapeutics President and CEO Frank Reynolds about InVivo’s technology and view a presentation about the company’s research.
Read More

InVivo Therapeutics sponsors Rise Above Paralysis Gala
January 15, 2010
InVivo Therapeutics will be the lead champion level sponsor for the black tie gala fundraiser to support the Greater Boston Chapter of the National Spinal Cord Injury Association, a non-profit organization that offers programs and services to those with spinal cord injury/disease (SCI). The RISE Above Paralysis Gala will take place on at 6:00pm on March 20, 2010 at the Hyatt Hotel at Logan Airport in East Boston.
Read More